Association of Follicular Distribution Patterns in Polycystic Ovaries with Clinical Outcomes in Assisted Reproductive Technology Cycles: A Prospective Cohort Study

نویسندگان

1 Department of Gynecology and Obstetrics, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

2 Breast Disease Research Center (BDRC), Tehran University of Medical Sciences, Tehran, Iran

3 Department of Gynecology and Obstetrics, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran

5 Department of Infertility, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

6 Department of Gynecology and Obstetrics, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

7 Department of Infertility, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

8 Department of Gynecology and Obstetrics, Arash Women’s Hospital, Tehran University of Medical Sciences, Tehran, Iran

doi
10.22074/ijfs.2024.2027697.1674
چکیده

Background: This study aims to evaluate the crucial relationship between the follicular distribution pattern (FDP) inpolycystic ovaries and its impact on reproductive outcomes. Recognizing these correlations is essential for optimizingassisted reproductive treatments and improving fertility outcomes in polycystic ovary syndrome (PCOS) patients.Materials and Methods: This prospective cohort study included women diagnosed with PCOS who were referredfor IVF/ICSI treatment at the Arash Women’s Hospital. Patient screening was conducted between March 2022 andSeptember 2023. Ultrasound imaging was performed on cycle days 2-3 of either natural menstrual cycles or thoseinduced by progestin to assess follicular distribution and ovarian characteristics. Ovarian ultrasound images were classifiedbased on the Rotterdam criteria. The association between the FDP and the menstrual status, luteinizing hormone(LH) and Anti-Müllerian hormone (AMH) levels, as well as total number of retrieved and metaphase II oocytes andthe rate of ovarian hyperstimulation syndrome (OHSS) at risk were evaluated.Results: Of the 157 PCOS patients evaluated during the study period, 73 patients were classified in the peripheralcystic pattern (PCP) ovaries group and 84 patients in the general cystic pattern (GCP) ovaries group. There was nostatistically significant difference in age and body mass index between groups. The mean serum levels of LH, AMH,total testosterone, and 17-OHP in the PCP group were significantly higher than the GCP group (P=0.022, P=0.023,P<00.001, and P=0.028, respectively). The number of retrieved oocytes and the OHSS at risk rate in the PCP groupwere notably greater than the GCP group.Conclusion: It seems that the FDP as a distinguishing factor among individuals diagnosed with PCOS could greatly assistin selecting a more personalized treatment approach and accurately predicting the treatment response rate.